

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.27012906 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 6.27012906 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.14304648 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.14304648 |
| 5 | oxygen transport (GO:0015671) | 5.96211821 |
| 6 | cysteine metabolic process (GO:0006534) | 5.52266277 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.50969464 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.39584691 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.39584691 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.34394711 |
| 11 | lysine metabolic process (GO:0006553) | 5.27203312 |
| 12 | lysine catabolic process (GO:0006554) | 5.27203312 |
| 13 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.19078407 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10048579 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10048579 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 5.10048579 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10048579 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 5.10048579 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10048579 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.05984746 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03709828 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.98295020 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.94803659 |
| 24 | hemoglobin metabolic process (GO:0020027) | 4.92811836 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.87972346 |
| 26 | gas transport (GO:0015669) | 4.81254400 |
| 27 | glycine metabolic process (GO:0006544) | 4.67015905 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.66805675 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.66805675 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.66805675 |
| 31 | kynurenine metabolic process (GO:0070189) | 4.66800596 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66049694 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.61032855 |
| 34 | serine family amino acid metabolic process (GO:0009069) | 4.56254385 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52227969 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.48113710 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.44076232 |
| 38 | tryptophan metabolic process (GO:0006568) | 4.43461972 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43445596 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 4.43126009 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.33944930 |
| 42 | detection of bacterium (GO:0016045) | 4.33802867 |
| 43 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.31628029 |
| 44 | bile acid biosynthetic process (GO:0006699) | 4.30605161 |
| 45 | urea metabolic process (GO:0019627) | 4.27967317 |
| 46 | urea cycle (GO:0000050) | 4.27967317 |
| 47 | detection of other organism (GO:0098543) | 4.26841993 |
| 48 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.23191735 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22863722 |
| 50 | modulation by virus of host process (GO:0019054) | 4.21628518 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.06821544 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 4.02850415 |
| 53 | drug transmembrane transport (GO:0006855) | 4.02283068 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.00112636 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.99546143 |
| 56 | aspartate family amino acid catabolic process (GO:0009068) | 3.96653523 |
| 57 | erythrocyte maturation (GO:0043249) | 3.94802481 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.94011594 |
| 59 | response to peptidoglycan (GO:0032494) | 3.91497551 |
| 60 | urate metabolic process (GO:0046415) | 3.88774161 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.86630082 |
| 62 | carnitine metabolic process (GO:0009437) | 3.85715655 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.83710354 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.79524298 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.79320715 |
| 66 | respiratory burst (GO:0045730) | 3.77338215 |
| 67 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76762475 |
| 68 | protein carboxylation (GO:0018214) | 3.76762475 |
| 69 | leukocyte aggregation (GO:0070486) | 3.75879744 |
| 70 | modulation by symbiont of host cellular process (GO:0044068) | 3.75528635 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.73761030 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 3.71155760 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 3.68239104 |
| 74 | erythrocyte development (GO:0048821) | 3.67087735 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66115640 |
| 76 | neutrophil activation (GO:0042119) | 3.65579760 |
| 77 | valine metabolic process (GO:0006573) | 3.65568357 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.64928007 |
| 79 | ethanol oxidation (GO:0006069) | 3.64690642 |
| 80 | bile acid metabolic process (GO:0008206) | 3.63364921 |
| 81 | regulation of protein activation cascade (GO:2000257) | 3.61894273 |
| 82 | regulation of fibrinolysis (GO:0051917) | 3.60694073 |
| 83 | aldehyde catabolic process (GO:0046185) | 3.60262886 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 3.60040946 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.59264314 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.59264314 |
| 87 | tyrosine metabolic process (GO:0006570) | 3.59045537 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 3.58857704 |
| 89 | complement activation, alternative pathway (GO:0006957) | 3.58804429 |
| 90 | drug transport (GO:0015893) | 3.58404848 |
| 91 | fatty acid oxidation (GO:0019395) | 3.56627881 |
| 92 | drug catabolic process (GO:0042737) | 3.54998735 |
| 93 | hepatocyte apoptotic process (GO:0097284) | 3.54548093 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.52017878 |
| 95 | GDP-mannose metabolic process (GO:0019673) | 3.51872213 |
| 96 | acylglycerol homeostasis (GO:0055090) | 3.51167910 |
| 97 | triglyceride homeostasis (GO:0070328) | 3.51167910 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.49449530 |
| 99 | organic acid catabolic process (GO:0016054) | 3.49449530 |
| 100 | lipid oxidation (GO:0034440) | 3.47952528 |
| 101 | response to mercury ion (GO:0046689) | 3.47114103 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46983005 |
| 103 | cellular response to virus (GO:0098586) | 3.42932510 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.42813443 |
| 105 | response to interleukin-15 (GO:0070672) | 3.42727808 |
| 106 | plasma lipoprotein particle clearance (GO:0034381) | 3.41597301 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 3.41367517 |
| 108 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.40477255 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.39962923 |
| 110 | response to host immune response (GO:0052572) | 3.39847485 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39847485 |
| 112 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39846087 |
| 113 | regulation of complement activation (GO:0030449) | 3.39426409 |
| 114 | glutamate metabolic process (GO:0006536) | 3.38934811 |
| 115 | granulocyte activation (GO:0036230) | 3.38424272 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 3.35523605 |
| 117 | response to nitrosative stress (GO:0051409) | 3.34469987 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.34432966 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 3.33639695 |
| 120 | monocarboxylic acid catabolic process (GO:0072329) | 3.33121719 |
| 121 | reverse cholesterol transport (GO:0043691) | 3.32419967 |
| 122 | coenzyme catabolic process (GO:0009109) | 3.32030943 |
| 123 | L-serine metabolic process (GO:0006563) | 3.31293739 |
| 124 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30610588 |
| 125 | proline metabolic process (GO:0006560) | 3.30520561 |
| 126 | viral protein processing (GO:0019082) | 3.30293484 |
| 127 | regulation of cholesterol esterification (GO:0010872) | 3.30126118 |
| 128 | cellular glucuronidation (GO:0052695) | 3.29907809 |
| 129 | tricarboxylic acid metabolic process (GO:0072350) | 3.28494241 |
| 130 | protein-lipid complex remodeling (GO:0034368) | 3.27466386 |
| 131 | macromolecular complex remodeling (GO:0034367) | 3.27466386 |
| 132 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27466386 |
| 133 | branched-chain amino acid metabolic process (GO:0009081) | 3.26851284 |
| 134 | organic cation transport (GO:0015695) | 3.24830726 |
| 135 | indolalkylamine metabolic process (GO:0006586) | 3.22565938 |
| 136 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.20723355 |
| 137 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.20723355 |
| 138 | ketone body metabolic process (GO:1902224) | 3.20114367 |
| 139 | folic acid metabolic process (GO:0046655) | 3.19862969 |
| 140 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19277501 |
| 141 | response to host (GO:0075136) | 3.19257933 |
| 142 | response to host defenses (GO:0052200) | 3.19257933 |
| 143 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19257933 |
| 144 | positive regulation of fibroblast migration (GO:0010763) | 3.17796574 |
| 145 | amine catabolic process (GO:0009310) | 3.17601632 |
| 146 | cellular biogenic amine catabolic process (GO:0042402) | 3.17601632 |
| 147 | imidazole-containing compound metabolic process (GO:0052803) | 3.17383215 |
| 148 | exogenous drug catabolic process (GO:0042738) | 3.16754563 |
| 149 | regulation of platelet aggregation (GO:0090330) | 3.16667272 |
| 150 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.15888768 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.14204729 |
| 152 | one-carbon metabolic process (GO:0006730) | 3.13284830 |
| 153 | cellular response to interleukin-15 (GO:0071350) | 3.12999772 |
| 154 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10526321 |
| 155 | heme transport (GO:0015886) | 3.09421649 |
| 156 | pentose-phosphate shunt (GO:0006098) | 3.09320143 |
| 157 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09257481 |
| 158 | sulfur amino acid metabolic process (GO:0000096) | 3.08844896 |
| 159 | negative regulation of interleukin-12 production (GO:0032695) | 3.08345413 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 3.06428733 |
| 161 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04027462 |
| 162 | negative regulation of necroptotic process (GO:0060546) | 2.98749986 |
| 163 | leukocyte degranulation (GO:0043299) | 2.97544510 |
| 164 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94666570 |
| 165 | regulation of necroptotic process (GO:0060544) | 2.93645319 |
| 166 | myeloid cell activation involved in immune response (GO:0002275) | 2.92395741 |
| 167 | virion assembly (GO:0019068) | 2.92290414 |
| 168 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91904344 |
| 169 | immunoglobulin mediated immune response (GO:0016064) | 2.91431769 |
| 170 | neutrophil mediated immunity (GO:0002446) | 2.88308263 |
| 171 | myeloid cell development (GO:0061515) | 2.88084284 |
| 172 | regulation of superoxide anion generation (GO:0032928) | 2.86540740 |
| 173 | detection of biotic stimulus (GO:0009595) | 2.86370644 |
| 174 | cellular extravasation (GO:0045123) | 2.83937253 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83590626 |
| 176 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82943681 |
| 177 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78279943 |
| 178 | detection of molecule of bacterial origin (GO:0032490) | 2.74445510 |
| 179 | positive thymic T cell selection (GO:0045059) | 2.74413120 |
| 180 | regulation of chromatin binding (GO:0035561) | 2.73245902 |
| 181 | NADPH regeneration (GO:0006740) | 2.70890201 |
| 182 | * heme biosynthetic process (GO:0006783) | 2.69132665 |
| 183 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.65323778 |
| 184 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 2.65251168 |
| 185 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65004140 |
| 186 | microglial cell activation (GO:0001774) | 2.64894861 |
| 187 | regulation of regulated secretory pathway (GO:1903305) | 2.62970328 |
| 188 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62779414 |
| 189 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.62630349 |
| 190 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.62397087 |
| 191 | regulation of T cell tolerance induction (GO:0002664) | 2.60351286 |
| 192 | negative regulation of glial cell proliferation (GO:0060253) | 2.58762773 |
| 193 | NIK/NF-kappaB signaling (GO:0038061) | 2.58228641 |
| 194 | thymic T cell selection (GO:0045061) | 2.56900356 |
| 195 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.56307750 |
| 196 | regulation of defense response to virus by virus (GO:0050690) | 2.56141426 |
| 197 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55585178 |
| 198 | negative regulation of interleukin-6 production (GO:0032715) | 2.55564411 |
| 199 | macrophage activation (GO:0042116) | 2.54666526 |
| 200 | regulation of B cell differentiation (GO:0045577) | 2.52922821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.44134437 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.18556265 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.78063244 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.46135309 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74511359 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.65609605 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.46585844 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.09386630 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02288424 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.97191606 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.79049976 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42333863 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39373050 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11989864 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10680383 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.07497073 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.06601833 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04617487 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00563323 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99641156 |
| 21 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98718226 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96087839 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95277271 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92947098 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.90319261 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88193412 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87955750 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.87223107 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.84656014 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82978913 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.82759904 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82312065 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82197049 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 1.81256604 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80517418 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.77618538 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.77382878 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75089678 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.74029699 |
| 40 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73142313 |
| 41 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.69796371 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68954968 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65973113 |
| 44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64839478 |
| 45 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63925199 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63580127 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62849850 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62719184 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61924230 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61331160 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60385953 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58159728 |
| 53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57433597 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56605004 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53721942 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52502946 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52064529 |
| 58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49258839 |
| 59 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47696892 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.47246654 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47139029 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41144939 |
| 63 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.40745083 |
| 64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39822511 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39446008 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37020713 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.36646529 |
| 68 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36568124 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36098366 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35735378 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35016791 |
| 72 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33391523 |
| 73 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32970745 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31998647 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30413164 |
| 76 | MYB_26560356_Chip-Seq_TH2_Human | 1.30235302 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29650032 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29194022 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27897139 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27006923 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25530735 |
| 82 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.25421849 |
| 83 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25130225 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.24260546 |
| 85 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23397156 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21853084 |
| 87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20524382 |
| 88 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19352447 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19149819 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18507726 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18441158 |
| 92 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.17435479 |
| 93 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16946372 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16824235 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16645936 |
| 96 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16481344 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16271006 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13637089 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11638143 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11564669 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11259545 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10694936 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09322090 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08739230 |
| 105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08399775 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08076281 |
| 107 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06873145 |
| 108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06061108 |
| 109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05204948 |
| 110 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04213847 |
| 111 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03718919 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03636453 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03278216 |
| 114 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.03075611 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02963236 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02917868 |
| 117 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02212857 |
| 118 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.02054262 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01910347 |
| 120 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01350138 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01045380 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99931936 |
| 123 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99753195 |
| 124 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99421840 |
| 125 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98687811 |
| 126 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.98538024 |
| 127 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97697835 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97566681 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97059109 |
| 130 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95010861 |
| 131 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.93540800 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93423369 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93117740 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91502575 |
| 135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.91065742 |
| 136 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89599665 |
| 137 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88803820 |
| 138 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88786296 |
| 139 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88684966 |
| 140 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88619024 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87968209 |
| 142 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87466240 |
| 143 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.87465578 |
| 144 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86386198 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 0.84626638 |
| 146 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84103017 |
| 147 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83989018 |
| 148 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83699082 |
| 149 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83581177 |
| 150 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83451507 |
| 151 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83392103 |
| 152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83298379 |
| 153 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82763411 |
| 154 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82420358 |
| 155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81770989 |
| 156 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81114375 |
| 157 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81044384 |
| 158 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.80014218 |
| 159 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79376134 |
| 160 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79322456 |
| 161 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79048243 |
| 162 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78497379 |
| 163 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77965507 |
| 164 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77423920 |
| 165 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77368896 |
| 166 | * MYC_22102868_ChIP-Seq_BL_Human | 0.76848389 |
| 167 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76732484 |
| 168 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76648445 |
| 169 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.76623862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.90419094 |
| 2 | MP0005360_urolithiasis | 6.37537162 |
| 3 | MP0005365_abnormal_bile_salt | 4.96476339 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.88045460 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.33215888 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.91850737 |
| 7 | MP0003436_decreased_susceptibility_to | 3.79588789 |
| 8 | MP0003303_peritoneal_inflammation | 3.25901074 |
| 9 | MP0009840_abnormal_foam_cell | 3.09468979 |
| 10 | MP0008260_abnormal_autophagy | 3.07925684 |
| 11 | MP0003252_abnormal_bile_duct | 3.04137393 |
| 12 | MP0005332_abnormal_amino_acid | 3.02011165 |
| 13 | MP0005083_abnormal_biliary_tract | 2.94158412 |
| 14 | MP0003724_increased_susceptibility_to | 2.94151992 |
| 15 | MP0003195_calcinosis | 2.90716403 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.75510399 |
| 17 | MP0002419_abnormal_innate_immunity | 2.50374909 |
| 18 | MP0005025_abnormal_response_to | 2.42294642 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.41721820 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.40597677 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.38092083 |
| 22 | MP0000685_abnormal_immune_system | 2.34258538 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.28661116 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.19544320 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.12728501 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.11114815 |
| 27 | MP0005387_immune_system_phenotype | 2.10116893 |
| 28 | MP0001790_abnormal_immune_system | 2.10116893 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 2.08730382 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.08374212 |
| 31 | MP0003186_abnormal_redox_activity | 2.07570737 |
| 32 | MP0005000_abnormal_immune_tolerance | 2.07358718 |
| 33 | MP0001819_abnormal_immune_cell | 2.06720118 |
| 34 | MP0001800_abnormal_humoral_immune | 2.05372839 |
| 35 | MP0009643_abnormal_urine_homeostasis | 2.03431331 |
| 36 | MP0009785_altered_susceptibility_to | 2.00218985 |
| 37 | MP0005671_abnormal_response_to | 1.99937540 |
| 38 | MP0002398_abnormal_bone_marrow | 1.97729420 |
| 39 | MP0002723_abnormal_immune_serum | 1.93651787 |
| 40 | MP0009278_abnormal_bone_marrow | 1.93218222 |
| 41 | MP0000609_abnormal_liver_physiology | 1.92934423 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.88957684 |
| 43 | MP0002405_respiratory_system_inflammati | 1.88696250 |
| 44 | MP0006082_CNS_inflammation | 1.85637152 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.81868770 |
| 46 | MP0003866_abnormal_defecation | 1.79632086 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.79561558 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.76310764 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.75883518 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.74632284 |
| 51 | MP0003878_abnormal_ear_physiology | 1.73081787 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.73081787 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.72360036 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.72360036 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.72111662 |
| 56 | MP0000490_abnormal_crypts_of | 1.70570692 |
| 57 | MP0002722_abnormal_immune_system | 1.68638401 |
| 58 | MP0004381_abnormal_hair_follicle | 1.66885165 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.65087667 |
| 60 | MP0004947_skin_inflammation | 1.64628866 |
| 61 | MP0001764_abnormal_homeostasis | 1.64052617 |
| 62 | MP0000716_abnormal_immune_system | 1.63986188 |
| 63 | MP0005670_abnormal_white_adipose | 1.62661964 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.60570199 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.60123738 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.58590943 |
| 67 | MP0002429_abnormal_blood_cell | 1.57619828 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.57485820 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.56086874 |
| 70 | MP0000858_altered_metastatic_potential | 1.53515640 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.53320582 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.47084201 |
| 73 | MP0001873_stomach_inflammation | 1.47081043 |
| 74 | MP0004043_abnormal_pH_regulation | 1.45867719 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44580492 |
| 76 | MP0001756_abnormal_urination | 1.37613356 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.36494089 |
| 78 | MP0004858_abnormal_nervous_system | 1.30607123 |
| 79 | MP0000598_abnormal_liver_morphology | 1.29214496 |
| 80 | MP0003868_abnormal_feces_composition | 1.25672602 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.25315637 |
| 82 | MP0005310_abnormal_salivary_gland | 1.25154042 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 1.22193238 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.12044422 |
| 85 | MP0005410_abnormal_fertilization | 1.11928776 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.11707670 |
| 87 | MP0001851_eye_inflammation | 1.10437056 |
| 88 | MP0003566_abnormal_cell_adhesion | 1.06760465 |
| 89 | MP0005451_abnormal_body_composition | 1.05263421 |
| 90 | MP0005666_abnormal_adipose_tissue | 1.00669552 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.99490923 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.98623434 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.97977719 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.97389264 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.97048237 |
| 96 | MP0003828_pulmonary_edema | 0.95431596 |
| 97 | MP0001849_ear_inflammation | 0.94664702 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.92166860 |
| 99 | MP0009931_abnormal_skin_appearance | 0.90814186 |
| 100 | MP0003075_altered_response_to | 0.89971460 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.89612002 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.87870206 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.87630946 |
| 104 | MP0003011_delayed_dark_adaptation | 0.87443315 |
| 105 | MP0005266_abnormal_metabolism | 0.86817887 |
| 106 | MP0001663_abnormal_digestive_system | 0.86538540 |
| 107 | MP0004147_increased_porphyrin_level | 0.86444192 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.86304025 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.85290553 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.83565322 |
| 111 | MP0009053_abnormal_anal_canal | 0.83531069 |
| 112 | MP0000313_abnormal_cell_death | 0.80894388 |
| 113 | MP0009763_increased_sensitivity_to | 0.80641451 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.80003297 |
| 115 | MP0008469_abnormal_protein_level | 0.79431399 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.78776370 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.77348819 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.77276812 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.74127022 |
| 120 | MP0004957_abnormal_blastocyst_morpholog | 0.73029178 |
| 121 | MP0008874_decreased_physiological_sensi | 0.71736349 |
| 122 | MP0009672_abnormal_birth_weight | 0.71236749 |
| 123 | MP0002971_abnormal_brown_adipose | 0.70045516 |
| 124 | MP0004510_myositis | 0.69437473 |
| 125 | MP0001661_extended_life_span | 0.68565221 |
| 126 | MP0003943_abnormal_hepatobiliary_system | 0.68288236 |
| 127 | MP0000358_abnormal_cell_content/ | 0.67782608 |
| 128 | MP0002269_muscular_atrophy | 0.67267612 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.66828055 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.66797158 |
| 131 | MP0000343_altered_response_to | 0.66533659 |
| 132 | MP0010352_gastrointestinal_tract_polyps | 0.65977198 |
| 133 | MP0002166_altered_tumor_susceptibility | 0.65679500 |
| 134 | MP0005647_abnormal_sex_gland | 0.64718691 |
| 135 | MP0004883_abnormal_blood_vessel | 0.63585636 |
| 136 | MP0005408_hypopigmentation | 0.63037961 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.62729598 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.62003204 |
| 139 | MP0002970_abnormal_white_adipose | 0.61953560 |
| 140 | MP0005390_skeleton_phenotype | 0.59628638 |
| 141 | MP0005621_abnormal_cell_physiology | 0.59542648 |
| 142 | MP0004130_abnormal_muscle_cell | 0.59458987 |
| 143 | MP0005334_abnormal_fat_pad | 0.58885868 |
| 144 | MP0003646_muscle_fatigue | 0.58497724 |
| 145 | MP0009764_decreased_sensitivity_to | 0.56794210 |
| 146 | MP0002796_impaired_skin_barrier | 0.55563461 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.55120674 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.53471218 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.53102138 |
| 150 | MP0005023_abnormal_wound_healing | 0.53084924 |
| 151 | MP0001730_embryonic_growth_arrest | 0.52784806 |
| 152 | MP0003718_maternal_effect | 0.52418140 |
| 153 | MP0009697_abnormal_copulation | 0.51991869 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.51826437 |
| 155 | MP0003959_abnormal_lean_body | 0.51045848 |
| 156 | MP0003111_abnormal_nucleus_morphology | 0.50970677 |
| 157 | MP0005501_abnormal_skin_physiology | 0.49577163 |
| 158 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49519961 |
| 159 | MP0005395_other_phenotype | 0.49398673 |
| 160 | MP0005330_cardiomyopathy | 0.49003204 |
| 161 | MP0003300_gastrointestinal_ulcer | 0.48779633 |
| 162 | MP0004185_abnormal_adipocyte_glucose | 0.48602279 |
| 163 | MP0002928_abnormal_bile_duct | 0.48218957 |
| 164 | MP0003953_abnormal_hormone_level | 0.48066713 |
| 165 | MP0000604_amyloidosis | 0.44837971 |
| 166 | MP0003638_abnormal_response/metabolism_ | 0.44274493 |
| 167 | MP0001929_abnormal_gametogenesis | 0.43671360 |
| 168 | MP0005535_abnormal_body_temperature | 0.43424057 |
| 169 | MP0010368_abnormal_lymphatic_system | 0.42912485 |
| 170 | MP0009115_abnormal_fat_cell | 0.39904782 |
| 171 | MP0008873_increased_physiological_sensi | 0.39897158 |
| 172 | MP0002132_abnormal_respiratory_system | 0.37386745 |
| 173 | MP0005448_abnormal_energy_balance | 0.37108688 |
| 174 | MP0000230_abnormal_systemic_arterial | 0.36307624 |
| 175 | MP0003283_abnormal_digestive_organ | 0.36024640 |
| 176 | MP0002080_prenatal_lethality | 0.35872114 |
| 177 | MP0000639_abnormal_adrenal_gland | 0.35442308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.21256235 |
| 2 | Hypochromic anemia (HP:0001931) | 6.38431679 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.11480312 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.67321077 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.21074808 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 5.08869571 |
| 7 | Microcytic anemia (HP:0001935) | 5.03633654 |
| 8 | Xanthomatosis (HP:0000991) | 4.84116828 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.83849908 |
| 10 | Deep venous thrombosis (HP:0002625) | 4.75190827 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.63257013 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.49787100 |
| 13 | Ketosis (HP:0001946) | 4.46695726 |
| 14 | Hypoglycemic coma (HP:0001325) | 4.45818398 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.43383837 |
| 16 | Hyperammonemia (HP:0001987) | 4.43128353 |
| 17 | Hyperglycinuria (HP:0003108) | 4.40898932 |
| 18 | Abnormal hemoglobin (HP:0011902) | 4.15373669 |
| 19 | Myositis (HP:0100614) | 4.14070556 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.05130771 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.05130771 |
| 22 | Hyperglycinemia (HP:0002154) | 4.01326387 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.00663655 |
| 24 | Gout (HP:0001997) | 3.94545916 |
| 25 | Urticaria (HP:0001025) | 3.94074364 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.92774072 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.88327754 |
| 28 | Obstructive lung disease (HP:0006536) | 3.88327754 |
| 29 | Ketoacidosis (HP:0001993) | 3.81073531 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 3.73929080 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.73887080 |
| 32 | Orchitis (HP:0100796) | 3.71468851 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 3.67623825 |
| 34 | Stomatitis (HP:0010280) | 3.61580038 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.57248648 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.55925345 |
| 37 | Increased IgE level (HP:0003212) | 3.51057750 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.50556963 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49583277 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.48381512 |
| 41 | Prolonged bleeding time (HP:0003010) | 3.46679243 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.44486368 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.44071419 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 3.44071419 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.42477701 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36895556 |
| 47 | Petechiae (HP:0000967) | 3.36088161 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 3.28059934 |
| 49 | Complement deficiency (HP:0004431) | 3.26682433 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.25269759 |
| 51 | Generalized aminoaciduria (HP:0002909) | 3.24430884 |
| 52 | Polycythemia (HP:0001901) | 3.19960618 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 3.16665788 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.12475676 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.11046407 |
| 56 | Proximal tubulopathy (HP:0000114) | 3.08769312 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 3.04511747 |
| 58 | Late onset (HP:0003584) | 3.03686875 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 3.03294451 |
| 60 | Slow saccadic eye movements (HP:0000514) | 3.02336006 |
| 61 | Cellulitis (HP:0100658) | 3.02133758 |
| 62 | Optic neuritis (HP:0100653) | 2.99555716 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.99555716 |
| 64 | Toxemia of pregnancy (HP:0100603) | 2.97734675 |
| 65 | Fat malabsorption (HP:0002630) | 2.96819908 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.96331799 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.95670667 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.95069597 |
| 69 | Lethargy (HP:0001254) | 2.94624323 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92666986 |
| 71 | Meningitis (HP:0001287) | 2.91771496 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.91438878 |
| 73 | Metabolic acidosis (HP:0001942) | 2.88851447 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87642774 |
| 75 | Gingivitis (HP:0000230) | 2.86645517 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.85037813 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.83459639 |
| 78 | Pustule (HP:0200039) | 2.82900196 |
| 79 | Recurrent skin infections (HP:0001581) | 2.81988586 |
| 80 | Joint hemorrhage (HP:0005261) | 2.75161598 |
| 81 | Epidermoid cyst (HP:0200040) | 2.71038957 |
| 82 | Nausea (HP:0002018) | 2.70362673 |
| 83 | Hyperuricemia (HP:0002149) | 2.70138144 |
| 84 | Increased purine levels (HP:0004368) | 2.70138144 |
| 85 | Increased serum ferritin (HP:0003281) | 2.67714514 |
| 86 | Encephalitis (HP:0002383) | 2.67401806 |
| 87 | Episodic fever (HP:0001954) | 2.67247201 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.62845232 |
| 89 | Abnormality of complement system (HP:0005339) | 2.61006341 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.59926401 |
| 91 | Cerebral edema (HP:0002181) | 2.59737560 |
| 92 | Malnutrition (HP:0004395) | 2.59485629 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.50600721 |
| 94 | Vomiting (HP:0002013) | 2.49840336 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 2.49424016 |
| 96 | Glycosuria (HP:0003076) | 2.49424016 |
| 97 | Anorexia (HP:0002039) | 2.47031945 |
| 98 | Hypercholesterolemia (HP:0003124) | 2.46175720 |
| 99 | Epistaxis (HP:0000421) | 2.45123846 |
| 100 | Gingival bleeding (HP:0000225) | 2.45121122 |
| 101 | Cholelithiasis (HP:0001081) | 2.39190979 |
| 102 | Alkalosis (HP:0001948) | 2.39063416 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.38987302 |
| 104 | Cholecystitis (HP:0001082) | 2.38987302 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38058704 |
| 106 | Irritability (HP:0000737) | 2.37891187 |
| 107 | Vasculitis (HP:0002633) | 2.36600619 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.34838558 |
| 109 | Spastic diplegia (HP:0001264) | 2.34398994 |
| 110 | Myoglobinuria (HP:0002913) | 2.32277351 |
| 111 | Vascular calcification (HP:0004934) | 2.31914888 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 2.30946270 |
| 113 | Osteomyelitis (HP:0002754) | 2.30244689 |
| 114 | Purpura (HP:0000979) | 2.27857264 |
| 115 | Increased IgM level (HP:0003496) | 2.27404800 |
| 116 | Hypertensive crisis (HP:0100735) | 2.27064913 |
| 117 | Chest pain (HP:0100749) | 2.25545193 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 2.23775828 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.22946599 |
| 120 | Rhabdomyolysis (HP:0003201) | 2.21067614 |
| 121 | Steatorrhea (HP:0002570) | 2.20992207 |
| 122 | Pancreatitis (HP:0001733) | 2.15031944 |
| 123 | Poikilocytosis (HP:0004447) | 2.13849231 |
| 124 | Hepatic necrosis (HP:0002605) | 2.13623398 |
| 125 | Neonatal onset (HP:0003623) | 2.13281101 |
| 126 | Multiple enchondromatosis (HP:0005701) | 2.12126008 |
| 127 | Brushfield spots (HP:0001088) | 2.11366958 |
| 128 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10747034 |
| 129 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10747034 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 2.09351761 |
| 131 | Hydroxyprolinuria (HP:0003080) | 2.09351761 |
| 132 | Recurrent viral infections (HP:0004429) | 2.07809440 |
| 133 | Abnormality of reticulocytes (HP:0004312) | 2.06528090 |
| 134 | Cardiovascular calcification (HP:0011915) | 2.06019916 |
| 135 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02384602 |
| 136 | Reticulocytosis (HP:0001923) | 2.02358260 |
| 137 | Enlarged kidneys (HP:0000105) | 2.02123635 |
| 138 | Hypertriglyceridemia (HP:0002155) | 2.00393189 |
| 139 | Keratoconjunctivitis (HP:0001096) | 2.00034162 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97926998 |
| 141 | Hyperphosphaturia (HP:0003109) | 1.97529666 |
| 142 | Skin nodule (HP:0200036) | 1.97306904 |
| 143 | Abnormal platelet volume (HP:0011876) | 1.97072509 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96866107 |
| 145 | Metaphyseal cupping (HP:0003021) | 1.96551588 |
| 146 | Abnormality of T cell physiology (HP:0011840) | 1.96528162 |
| 147 | Rickets (HP:0002748) | 1.95727748 |
| 148 | Opisthotonus (HP:0002179) | 1.95536468 |
| 149 | Granulocytopenia (HP:0001913) | 1.95032550 |
| 150 | Ragged-red muscle fibers (HP:0003200) | 1.94729059 |
| 151 | Cutaneous photosensitivity (HP:0000992) | 1.94701245 |
| 152 | Lymphopenia (HP:0001888) | 1.94284268 |
| 153 | Abnormality of the gallbladder (HP:0005264) | 1.93894751 |
| 154 | Abnormality of the pericardium (HP:0001697) | 1.93215642 |
| 155 | Increased muscle lipid content (HP:0009058) | 1.92481224 |
| 156 | Acanthocytosis (HP:0001927) | 1.92475563 |
| 157 | Colitis (HP:0002583) | 1.92085235 |
| 158 | Ileus (HP:0002595) | 1.91000900 |
| 159 | Pallor (HP:0000980) | 1.90587046 |
| 160 | Abnormality of T cells (HP:0002843) | 1.88096713 |
| 161 | Symptomatic seizures (HP:0011145) | 1.87802066 |
| 162 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87341963 |
| 163 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87341963 |
| 164 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87341963 |
| 165 | Hypergammaglobulinemia (HP:0010702) | 1.87238232 |
| 166 | Esophageal varix (HP:0002040) | 1.86916903 |
| 167 | Myocardial infarction (HP:0001658) | 1.86100005 |
| 168 | Gastrointestinal dysmotility (HP:0002579) | 1.86001679 |
| 169 | Panhypogammaglobulinemia (HP:0003139) | 1.84569884 |
| 170 | Nephrolithiasis (HP:0000787) | 1.84340224 |
| 171 | Hypochromic microcytic anemia (HP:0004840) | 1.84276167 |
| 172 | Sepsis (HP:0100806) | 1.83575208 |
| 173 | Insulin resistance (HP:0000855) | 1.83363032 |
| 174 | Abnormality of iron homeostasis (HP:0011031) | 1.81807321 |
| 175 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81700765 |
| 176 | Amyloidosis (HP:0011034) | 1.81697410 |
| 177 | Nasal polyposis (HP:0100582) | 1.81480930 |
| 178 | Severe visual impairment (HP:0001141) | 1.80480486 |
| 179 | Peritonitis (HP:0002586) | 1.80458668 |
| 180 | Arterial thrombosis (HP:0004420) | 1.79354692 |
| 181 | Skin ulcer (HP:0200042) | 1.79344976 |
| 182 | Pathologic fracture (HP:0002756) | 1.78229446 |
| 183 | Leukocytosis (HP:0001974) | 1.78040908 |
| 184 | Hypermelanotic macule (HP:0001034) | 1.76663375 |
| 185 | Splenomegaly (HP:0001744) | 1.74880983 |
| 186 | IgM deficiency (HP:0002850) | 1.74856930 |
| 187 | Increased cerebral lipofuscin (HP:0011813) | 1.73896635 |
| 188 | Glomerulopathy (HP:0100820) | 1.70567027 |
| 189 | Myopathic facies (HP:0002058) | 1.69912730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.81295666 |
| 2 | ERN1 | 3.49315828 |
| 3 | RIPK4 | 3.33635172 |
| 4 | TRIB3 | 3.23295962 |
| 5 | MAP4K1 | 3.03547105 |
| 6 | PDK3 | 2.69443270 |
| 7 | PDK4 | 2.69443270 |
| 8 | PKN2 | 2.68416019 |
| 9 | TAOK2 | 2.59780077 |
| 10 | IRAK4 | 2.55769087 |
| 11 | SMG1 | 2.48860086 |
| 12 | PRPF4B | 2.48707702 |
| 13 | EIF2AK1 | 2.41942291 |
| 14 | WNK4 | 2.37896825 |
| 15 | TESK1 | 2.32050615 |
| 16 | TNK2 | 2.27814273 |
| 17 | EPHB1 | 2.12595149 |
| 18 | FLT3 | 2.05894978 |
| 19 | NME2 | 1.98158660 |
| 20 | FGFR4 | 1.90057967 |
| 21 | SIK1 | 1.88300654 |
| 22 | EPHA2 | 1.87694933 |
| 23 | NEK1 | 1.84201883 |
| 24 | WNK3 | 1.84043529 |
| 25 | TESK2 | 1.78359860 |
| 26 | CSK | 1.72231655 |
| 27 | BUB1 | 1.69292903 |
| 28 | FES | 1.63048624 |
| 29 | MAP3K1 | 1.58971631 |
| 30 | KDR | 1.57814931 |
| 31 | WEE1 | 1.54809495 |
| 32 | PDK2 | 1.54343702 |
| 33 | MAP3K11 | 1.54169221 |
| 34 | BLK | 1.51459109 |
| 35 | SIK3 | 1.45834196 |
| 36 | FGR | 1.45297844 |
| 37 | MAP3K10 | 1.41938200 |
| 38 | HCK | 1.40179280 |
| 39 | KSR2 | 1.31937488 |
| 40 | STK38L | 1.31901433 |
| 41 | MAPKAPK3 | 1.28730292 |
| 42 | NEK2 | 1.26415340 |
| 43 | MAPK11 | 1.25789058 |
| 44 | MAPK15 | 1.24009313 |
| 45 | BTK | 1.23448357 |
| 46 | DYRK1B | 1.23073805 |
| 47 | STK16 | 1.22094607 |
| 48 | PRKD2 | 1.22045367 |
| 49 | MAP3K3 | 1.18556488 |
| 50 | MST1R | 1.16428840 |
| 51 | ICK | 1.16166095 |
| 52 | TTK | 1.16019218 |
| 53 | SCYL2 | 1.14759285 |
| 54 | MAP2K2 | 1.14674049 |
| 55 | MAP2K3 | 1.09187823 |
| 56 | ABL2 | 1.07625927 |
| 57 | JAK3 | 1.05658931 |
| 58 | PTK6 | 1.03774310 |
| 59 | NEK9 | 1.02763713 |
| 60 | PAK4 | 1.02346072 |
| 61 | PASK | 0.99944831 |
| 62 | DYRK3 | 0.99373900 |
| 63 | SYK | 0.95290988 |
| 64 | INSRR | 0.94072539 |
| 65 | MARK2 | 0.92189200 |
| 66 | MARK3 | 0.92165599 |
| 67 | PRKD3 | 0.91730091 |
| 68 | MAP3K8 | 0.91376560 |
| 69 | LRRK2 | 0.91375139 |
| 70 | TLK1 | 0.88915632 |
| 71 | IKBKE | 0.88836550 |
| 72 | MET | 0.87155080 |
| 73 | EIF2AK3 | 0.86821975 |
| 74 | EEF2K | 0.86209675 |
| 75 | PDPK1 | 0.85727272 |
| 76 | PTK2B | 0.84572085 |
| 77 | BRSK2 | 0.84007394 |
| 78 | PIK3CG | 0.82918024 |
| 79 | CDK4 | 0.82817204 |
| 80 | RPS6KB2 | 0.81931777 |
| 81 | ACVR1B | 0.81409760 |
| 82 | LYN | 0.80258698 |
| 83 | CDK19 | 0.79262174 |
| 84 | TAOK3 | 0.75572633 |
| 85 | HIPK2 | 0.72991030 |
| 86 | PDK1 | 0.72924169 |
| 87 | ERBB4 | 0.72358381 |
| 88 | PIM2 | 0.71135023 |
| 89 | AURKA | 0.70719475 |
| 90 | RPS6KA4 | 0.70533073 |
| 91 | PTK2 | 0.69353393 |
| 92 | STK38 | 0.68256005 |
| 93 | CDK12 | 0.66545889 |
| 94 | SIK2 | 0.64789266 |
| 95 | IRAK2 | 0.64761565 |
| 96 | MTOR | 0.64719545 |
| 97 | LCK | 0.64179344 |
| 98 | MAPKAPK2 | 0.63997076 |
| 99 | YES1 | 0.62682661 |
| 100 | TBK1 | 0.60336979 |
| 101 | MAP3K2 | 0.59699747 |
| 102 | GRK6 | 0.58021003 |
| 103 | ZAP70 | 0.58002252 |
| 104 | PINK1 | 0.57519431 |
| 105 | CDK7 | 0.57305038 |
| 106 | MYLK | 0.57071814 |
| 107 | PRKG2 | 0.56718080 |
| 108 | IRAK3 | 0.56681053 |
| 109 | AURKB | 0.55712215 |
| 110 | CDK6 | 0.54109513 |
| 111 | CSF1R | 0.52691508 |
| 112 | CLK1 | 0.52625268 |
| 113 | PLK1 | 0.52516969 |
| 114 | BRSK1 | 0.52329319 |
| 115 | RPS6KC1 | 0.51085370 |
| 116 | RPS6KL1 | 0.51085370 |
| 117 | CDC7 | 0.49506261 |
| 118 | IKBKB | 0.48125945 |
| 119 | LATS1 | 0.47981700 |
| 120 | STK10 | 0.46904218 |
| 121 | RAF1 | 0.46215095 |
| 122 | PIM1 | 0.45975168 |
| 123 | TYK2 | 0.45610275 |
| 124 | LMTK2 | 0.45594946 |
| 125 | STK4 | 0.44994639 |
| 126 | FRK | 0.43686995 |
| 127 | MAP2K6 | 0.43419598 |
| 128 | PRKCI | 0.42786887 |
| 129 | RIPK1 | 0.42595519 |
| 130 | MAP3K13 | 0.41162733 |
| 131 | PRKAA1 | 0.40457372 |
| 132 | RPS6KA2 | 0.40077624 |
| 133 | STK11 | 0.39607646 |
| 134 | SGK3 | 0.39321518 |
| 135 | ITK | 0.39258422 |
| 136 | TAOK1 | 0.38703930 |
| 137 | BRAF | 0.38589181 |
| 138 | JAK2 | 0.38179920 |
| 139 | DAPK3 | 0.37916401 |
| 140 | MAPK12 | 0.37441899 |
| 141 | GSK3A | 0.36935269 |
| 142 | FYN | 0.36385029 |
| 143 | MAP3K7 | 0.36157986 |
| 144 | RPS6KA6 | 0.35831619 |
| 145 | MAP2K1 | 0.35826556 |
| 146 | TGFBR1 | 0.35709875 |
| 147 | MAP3K5 | 0.35405208 |
| 148 | ARAF | 0.35079880 |
| 149 | TXK | 0.34013102 |
| 150 | PAK2 | 0.33224673 |
| 151 | ERBB2 | 0.32958702 |
| 152 | PAK1 | 0.32078997 |
| 153 | BMX | 0.31923110 |
| 154 | MATK | 0.31599898 |
| 155 | CSNK2A1 | 0.30375270 |
| 156 | RET | 0.28764945 |
| 157 | MAP3K14 | 0.28696938 |
| 158 | IRAK1 | 0.27906481 |
| 159 | JAK1 | 0.27890360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13358273 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04905348 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.89194562 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78805011 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62021766 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61834280 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.58751043 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56291420 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55738097 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.55376144 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42963903 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36699602 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34455078 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.31762961 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30379470 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.29853006 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24529186 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.21761569 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15740595 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14732969 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.08720645 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.02115846 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99801839 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98095561 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.97785127 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95585645 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.95270164 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.93356276 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.88156837 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85423918 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81661173 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.80115974 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76789007 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75952165 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73137114 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72636141 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.70173517 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69442564 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67977110 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67671680 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67048236 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.66012507 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63994691 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62997677 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.60149566 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.59114852 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57510437 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55185755 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53389767 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53335623 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52369906 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45633605 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44565681 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.43645030 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43510896 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.43381158 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43328130 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41053670 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41051409 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38146003 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37413954 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37181744 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35364863 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34796473 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.34710258 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34185170 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32780973 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31648868 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 1.31464505 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30477051 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30439829 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 1.30116623 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29442559 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 1.28542397 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 1.25496387 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25335974 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25269868 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 1.20997293 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20580128 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20174290 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16532062 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16417407 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16252820 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 1.16239964 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15395877 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15304236 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 1.15042545 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14903282 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14679774 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14155300 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11620345 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 1.11084345 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08613028 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07896806 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06718214 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 1.06539472 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06072729 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 1.01778185 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01416803 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98612845 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98491911 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96480038 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93876926 |
| 104 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93019502 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92989723 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92945303 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92244138 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90678844 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90030447 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89215818 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87586705 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.87483270 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.84565260 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81657026 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81037278 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.80100818 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79977640 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79913124 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79691873 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79563833 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76589394 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76150270 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75294106 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.73515863 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73088693 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71570417 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71370544 |
| 128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71105895 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70938552 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.70823098 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69577317 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69140950 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68750742 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68313553 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67628433 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67352301 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65737951 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63941225 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62436954 |
| 140 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61149961 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60724757 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60722335 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59989409 |
| 144 | DNA replication_Homo sapiens_hsa03030 | 0.59380497 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58332746 |
| 146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58039550 |
| 147 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56734428 |
| 148 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56340258 |
| 149 | Glioma_Homo sapiens_hsa05214 | 0.53027372 |
| 150 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52866882 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.52782696 |
| 152 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51212299 |
| 153 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.50264231 |
| 154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48701090 |
| 155 | Proteasome_Homo sapiens_hsa03050 | 0.47879022 |
| 156 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47715196 |
| 157 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41468492 |
| 158 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40482663 |
| 159 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37766535 |
| 160 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32753366 |
| 161 | Ribosome_Homo sapiens_hsa03010 | 0.32727890 |
| 162 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32561631 |
| 163 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31976409 |
| 164 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29024482 |
| 165 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24496815 |
| 166 | Insulin resistance_Homo sapiens_hsa04931 | 0.24311803 |
| 167 | Mismatch repair_Homo sapiens_hsa03430 | 0.23861168 |
| 168 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22147414 |
| 169 | Protein export_Homo sapiens_hsa03060 | 0.19569560 |
| 170 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19076481 |
| 171 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18870466 |
| 172 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18303918 |
| 173 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16858784 |
| 174 | Bladder cancer_Homo sapiens_hsa05219 | 0.16574317 |
| 175 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15830509 |
| 176 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15446428 |
| 177 | Base excision repair_Homo sapiens_hsa03410 | 0.13954892 |
| 178 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11698615 |
| 179 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11409496 |
| 180 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09893597 |
| 181 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06136389 |
| 182 | RNA transport_Homo sapiens_hsa03013 | 0.06111756 |

